Literature DB >> 31927557

Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.

Yan Zhang1, Zhen Yuan1, Yannan Jiang1, Renbin Shen1, Menghui Gu1, Wei Xu1, Xinhua Gu1.   

Abstract

BACKGROUND Small nuclear ribonucleoproteins (snRNPs) complexes of protein and noncoding RNA accumulate in the cell nucleus and catalyze pre-mRNA splicing to form the spliceosome. This study aimed to investigate the role of the spliceosome, splicing factor 3b subunit 1 (SF3B1), in AGS and MKN28 human gastric cancer cells in vitro, including gene knockdown with small interfering RNA (siRNA), and the use of the selective mRNA splicing inhibitor of SF3B1, pladienolide B. MATERIAL AND METHODS In AGS and MKN28 human gastric cancer cells, SF3B1expression was inhibited with siRNA and pladienolide B. Following SF3B1 inhibition, the Cell Counting Kit-8 (CCK-8) assay measured cell proliferation, and flow cytometry was used to investigate cell apoptosis and cell cycle arrest. The downstream HOXA10 and AKT pathways were studied by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot. The presence of alternative splicing, or differential splicing, of single-gene coding for multiple proteins, was analyzed using The Cancer Genome Atlas (TCGA) SpliceSeq. RESULTS Inhibition of SF3B1 reduced the proliferation rate of AGS and MKN28 human gastric cancer cells by inducing apoptosis and G2/M phase arrest. SF3B1 knockdown resulted in reduced homeobox A10 (HOXA10) mRNA expression and expression of long noncoding RNA (lncRNA) isoforms of HOXA10 (exons 1 and 3) and HOXA10 (exons 2 and 3). SF3B1 inhibition increased PTEN levels and reduced AKT protein phosphorylation. CONCLUSIONS In AGS and MKN28 human gastric cancer cells in vitro, inhibition of SF3B1 reduced cell proliferation, induced apoptosis, and resulted in cell cycle arrest by regulating HOXA10 splicing.

Entities:  

Year:  2020        PMID: 31927557     DOI: 10.12659/MSM.919460

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

Review 1.  Alternative splicing of lncRNAs in human diseases.

Authors:  Jiaxi Chen; Yawen Liu; Jingyu Min; Huizhi Wang; Feifan Li; Chunhui Xu; Aihua Gong; Min Xu
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

Review 2.  Impact of Alternative Splicing Variants on Liver Cancer Biology.

Authors:  Jose J G Marin; Maria Reviejo; Meraris Soto; Elisa Lozano; Maitane Asensio; Sara Ortiz-Rivero; Carmen Berasain; Matias A Avila; Elisa Herraez
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

3.  Modification of Mcl-1 alternative splicing induces apoptosis and suppresses tumor proliferation in gastric cancer.

Authors:  Yonghong Li; Xiaoling Gao; Chaojun Wei; Rui Guo; Hui Xu; Zhongtian Bai; Jianye Zhou; Jun Zhu; Wanxia Wang; Yu Wu; Jingzhe Li; Zhongliang Zhang; Xiaodong Xie
Journal:  Aging (Albany NY)       Date:  2020-10-14       Impact factor: 5.682

4.  Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.

Authors:  Pooja Popli; Megan M Richters; Sangappa B Chadchan; Tae Hoon Kim; Eric Tycksen; Obi Griffith; Premal H Thaker; Malachi Griffith; Ramakrishna Kommagani
Journal:  Cell Death Dis       Date:  2020-10-10       Impact factor: 8.469

5.  Development and validation of an individual alternative splicing prognostic signature in gastric cancer.

Authors:  Shenghan Lou; Jian Zhang; Zhao Zhai; Xin Yin; Yimin Wang; Tianyi Fang; Yingwei Xue
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

Review 6.  Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma.

Authors:  I Gede Putu Supadmanaba; Giulia Mantini; Ornella Randazzo; Mjriam Capula; Ittai B Muller; Stella Cascioferro; Patrizia Diana; Godefridus J Peters; Elisa Giovannetti
Journal:  Epigenetics       Date:  2021-05-30       Impact factor: 4.528

7.  Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells.

Authors:  Katherine A Wood; Charlie F Rowlands; Huw B Thomas; Steven Woods; Julieta O'Flaherty; Sofia Douzgou; Susan J Kimber; William G Newman; Raymond T O'Keefe
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.